Genome engineering with designer nucleases is a rapidly progressing field, and the ability to correct human gene mutations in situ is highly desirable. We employed fibroblasts derived from a patient with Fanconi anemia as a model to test the ability of the clustered regularly interspaced short palindromic repeats/Cas9 nuclease system to mediate gene correction. We show that the Cas9 nuclease and nickase each resulted in gene correction, but the nickase, because of its ability to preferentially mediate homology-directed repair, resulted in a higher frequency of corrected clonal isolates. To assess the off-target effects, we used both a predictive software platform to identify intragenic sequences of homology as well as a genome-wide screen utilizing linear amplification-mediated PCR. We observed no off-target activity and show RNA-guided endonuclease candidate sites that do not possess low sequence complexity function in a highly specific manner. Collectively, we provide proof of principle for precision genome editing in Fanconi anemia, a DNA repair-deficient human disorder.
Get full access to this article
View all access options for this article.
References
1.
HuardCC, TremblayCS, HelsperK, et al.Fanconi anemia proteins interact with CtBP1 and modulate the expression of the Wnt antagonist Dickkopf-1. Blood, 2013; 121:1729–1739.
2.
WhitneyMA, JakobsP, KabackM, et al.The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population. Hum Mutat, 1994; 3:339–341.
3.
WhitneyMA, SaitoH, JakobsPM, et al.A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet, 1993; 4:202–205.
4.
GrompeM, D'AndreaA. Fanconi anemia and DNA repair. Hum Mol Genet, 2001; 10:2253–2259.
5.
PickeringA, ZhangJ, PanneerselvamJ, FeiP. Advances in the understanding of Fanconi anemia tumor suppressor pathway. Cancer Biol Ther, 2013; 14:1089–1091.
6.
MacMillanML, WagnerJE. Haematopoeitic cell transplantation for Fanconi anaemia—when and how?. Br J Haematol, 2010; 149:14–21.
7.
BarkerJN, DaviesSM, DeforT, et al.Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood, 2001; 97:2957–2961.
8.
DaviesSM, KhanS, WagnerJE, et al.Unrelated donor bone marrow transplantation for Fanconi anemia. Bone Marrow Transplant, 1996; 17:43–47.
9.
FagerlieSR, DiazJ, ChristiansonTA, et al.Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes. Blood, 2001; 97:3017–3024.
10.
HylandKA, OlsonER, ClarkKJ, et al.Sleeping Beauty-mediated correction of Fanconi anemia type C. J Gene Med, 2011; 13:462–469.
11.
Hacein-Bey-AbinaS, GarrigueA, WangGP, et al.Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest, 2008; 118:3132–3142.
12.
Hacein-Bey-AbinaS, Von KalleC, SchmidtM, et al.LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 2003; 302:415–419.
13.
MaederML, Thibodeau-BegannyS, OsiakA, et al.Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell, 2008; 31:294–301.
14.
CermakT, DoyleEL, ChristianM, et al.Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res, 2011; 39:e82.
15.
ChristianM, CermakT, DoyleEL, et al.Targeting DNA double-strand breaks with TAL effector nucleases. Genetics, 2010; 186:757–761.
16.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339:819–823.
17.
MaliP, YangL, EsveltKM, et al.RNA-guided human genome engineering via Cas9. Science, 2013; 339:823–826.
18.
JinekM, EastA, ChengA, et al.RNA-programmed genome editing in human cells. Elife, 2013; 2:e00471.
19.
KotinRM, LindenRM, BernsKI. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J, 1992; 11:5071–5078.
20.
SadelainM, PapapetrouEP, BushmanFD. Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer, 2011; 12:51–58.
21.
TanI, NgCH, LimL, LeungT. Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. J Biol Chem, 2001; 276:21209–21216.
22.
DeKelverRC, ChoiVM, MoehleEA, et al.Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res, 2010; 20:1133–1142.
23.
HockemeyerD, SoldnerF, BeardC, et al.Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol, 2009; 27:851–857.
24.
CummingRC, LiuJM, YoussoufianH, BuchwaldM. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood, 1996; 88:4558–4567.
25.
PangQ, ChristiansonTA, KeebleW, et al.The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. Blood, 2001; 98:1392–1401.
GuschinDY, WaiteAJ, KatibahGE, et al.A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol, 2010; 649:247–256.
28.
LombardoA, GenoveseP, BeausejourCM, et al.Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol, 2007; 25:1298–1306.
29.
MatraiJ, CantoreA, BartholomaeCC, et al.Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology, 2011; 53:1696–1707.
30.
GabrielR, LombardoA, ArensA, et al.An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol, 2011; 29:816–823.
31.
OsbornMJ, StarkerCG, McelroyAN, et al.TALEN-based gene correction for epidermolysis bullosa. Mol Ther, 2013; 21:1151–1159.
32.
ParuzynskiA, ArensA, GabrielR, et al.Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat Protoc, 2010; 5:1379–1395.
33.
ArensA, AppeltJU, BartholomaeCC, et al.Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites. Hum Gene Ther Methods, 2012; 23:111–118.
34.
BoitanoAE, WangJ, RomeoR, et al.Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science, 2010; 329:1345–1348.
35.
HsuPD, ScottDA, WeinsteinJA, et al.DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol, 2013; 31:827–832.
36.
GasiunasG, BarrangouR, HorvathP, SiksnysV. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA, 2012; 109:E2579–E2586.
37.
CertoMT, RyuBY, AnnisJE, et al.Tracking genome engineering outcome at individual DNA breakpoints. Nat Methods, 2011; 8:671–676.
38.
ChoSW, KimS, KimY, et al.Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res, 2014; 24:132–141.
39.
FuY, FodenJA, KhayterC, et al.High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol, 2013; 31:822–826.
40.
GabrielR, EckenbergR, ParuzynskiA, et al.Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med, 2009; 15:1431–1436.
41.
SmithC, GoreA, YanW, et al.Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell, 2014; 15:12–13.
42.
BrozovicA, DamrotJ, TsarykR, et al.Cisplatin sensitivity is related to late DNA damage processing and checkpoint control rather than to the early DNA damage response. Mutat Res, 2009; 670:32–41.
43.
ZouJ, MaederML, MaliP, et al.Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell, 2009; 5:97–110.
44.
DavisL, MaizelsN. Homology-directed repair of DNA nicks via pathways distinct from canonical double-strand break repair. Proc Natl Acad Sci USA, 2014; 111:E924–E932.
45.
MetzgerMJ, Mcconnell-SmithA, StoddardBL, MillerAD. Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template. Nucleic Acids Res, 2011; 39:926–935.
46.
RamirezCL, CertoMT, MussolinoC, et al.Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res, 2012; 40:5560–5568.
47.
WilberA, FrandsenJL, WangensteenKJ, et al.Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. Hum Gene Ther, 2005; 16:1325–1332.
48.
KitaoH, YamamotoK, MatsushitaN, et al.Functional interplay between BRCA2/FancD1 and FancC in DNA repair. J Biol Chem, 2006; 281:21312–21320.
49.
GenoveseP, SchiroliG, EscobarG, et al.Targeted genome editing in human repopulating haematopoietic stem cells. Nature, 2014; 510:235–240.
50.
GoesslingW, AllenRS, GuanX, et al.Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell, 2011; 8:445–458.
51.
DoyonY, VoTD, MendelMC, et al.Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods, 2011; 8:74–79.
52.
HoltN, WangJ, KimK, et al.Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol, 2010; 28:839–847.
53.
LombardoA, CesanaD, GenoveseP, et al.Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat Methods, 2011; 8:861–869.
54.
OrlandoSJ, SantiagoY, DekelverRC, et al.Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Res, 2010; 38:e152.
55.
HarlalkaGV, BapleEL, CrossH, et al.Mutation of HERC2 causes developmental delay with Angelman-like features. J Med Genet, 2013; 50:65–73.
56.
GerdinAK, SurveVV, JonssonM, et al.Phenotypic screening of hepatocyte nuclear factor (HNF) 4-gamma receptor knockout mice. Biochem Biophys Res Commun, 2006; 349:825–832.
57.
MakelaTP, HellstenE, VesaJ, et al.The rearranged L-myc fusion gene (RLF) encodes a Zn-15 related zinc finger protein. Oncogene, 1995; 11:2699–2704.
58.
KiyonakaS, NakajimaH, TakadaY, et al.Physical and functional interaction of the active zone protein CAST/ERC2 and the beta-subunit of the voltage-dependent Ca(2+) channel. J Biochem, 2012; 152:149–159.
59.
CradickTJ, FineEJ, AnticoCJ, BaoG. CRISPR/Cas9 systems targeting beta-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res, 2013; 41:9584–9592.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
